OCCL Ltd Q3 FY26 Share Price & Earnings Call Analysis

Financials of OCCL Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of OCCL Ltd

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +000010396107123120114149
Expenses +00008580899710094125
Operating Profit-0-0-0-019161926192024
OPM %18%16%17%21%16%17%16%
Other Income +000010101-32
Interest00002211111
Depreciation00007777777
Profit before tax-0-0-0-0107111812817
Tax %0%0%-20%100%26%26%24%28%25%23%-13%
Net Profit +00-0-0859139719
EPS in Rs1.501.051.742.631.741.313.87

Financials of OCCL Ltd

Profit & Loss

Annual income statement trend

Mar 2023Mar 2024Mar 2025Mar 2026
Sales +00307506
Expenses +00254417
Operating Profit-0-05389
OPM %17%18%
Other Income +0020
Interest0055
Depreciation002129
Profit before tax-0-02955
Tax %-33%-14%25%14%
Net Profit +-0-02148
EPS in Rs4.299.55
Dividend Payout %0%0%35%19%

Financials of OCCL Ltd

Balance Sheet

Capital structure and asset base

Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.010.011010
Reserves-0-0386421
Borrowings +006284
Other Liabilities +007686
Total Liabilities00534602
Fixed Assets +00379363
CWIP0032
Investments001114
Other Assets +00141222
Total Assets00534602

Financials of OCCL Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-07011
Cash from Investing Activity +04-17
Cash from Financing Activity +0-7410
Net Cash Flow004
Free Cash Flow-057-4
CFO/OP133%140%22%

Financials of OCCL Ltd

Ratios

Working capital efficiency and return ratios

Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days7761
Inventory Days188139
Days Payable7741
Cash Conversion Cycle189160
Working Capital Days6769
ROCE %-86%15%13%

Others in Chemicals & Petrochemicals this season

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Ch. (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

  • Deepak Fertilis. (Q1 FY27)

    Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF